The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen a reaction from the health care vote in Congress, or lack thereof.
DuPont, Chevron, Merck, and Pfizer sink the DJIA on Thursday.
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Chevron, Verizon, Pfizer, and Merck combined to weigh on the DJIA Tuesday.
Merck and Pfizer each saw their shares sink early on Monday after the firms gave an update on their type 2 diabetes treatment.
Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
Merck saw its shares slip on Wednesday after the firm reported that it will be halting its mid-to-late-stage clinical trial for the treatment of Alzheimer’s disease.
Chris Lange JPMorgan, Apple, Merck, and Goldman Sachs all set new 52-week highs and dominated the rising DJIA on Tuesday.
It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far the reaction has been quite positive.
Merck reported disappointing fourth-quarter financial results before the markets opened on Thursday.
Chris Lange 24/7 Wall St. has put together a preview of the two Dow stocks scheduled to report their quarterly results on Thursday: Merck and Visa.
Five of the Dow stocks are reporting next week, and this has the potential to sustain the run that the index has made since the Trump rally began and push it even…
The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly down.
